Claims Analysis
Total Claims: 62
Claim 1
Independent Claim
86 words
1 . A system for treating cardiac valve dysfunction, comprising: (a) a lead with electrodes configured for implantation in a patient such that the electrodes are in electrical communication with muscle tissue proximate to a cardiac valve to be treated; (b) stimulation circuitry in electrical communication with the lead for delivering electrical energy to the lead electrodes to stimulate contraction of the muscle tissue; and (c) control circuitry in communication with the stimulation circuitry for controlling the delivery of the electrical energy to the lead electrodes.
Claim 2
Dependent Claim
86 words
1 . A system for treating cardiac valve dysfunction, comprising: (a) a lead with electrodes configured for implantation in a patient such that the electrodes are in electrical communication with muscle tissue proximate to a cardiac valve to be treated; (b) stimulation circuitry in electrical communication with the lead for delivering electrical energy to the lead electrodes to stimulate contraction of the muscle tissue; and (c) control circuitry in communication with the stimulation circuitry for controlling the delivery of the electrical energy to the lead electrodes.
Claim 3
Dependent Claim
24 words
2 . The system of claim 1 , in which the lead is configured to be received within a blood vessel in the patient.
Claim 4
Dependent Claim
32 words
3 . The system of claim 2 , in which the blood vessel is the coronary sinus positioned next to muscle tissue that is proximate to the mitral valve of the patient.
Claim 5
Dependent Claim
46 words
4 . The system of claim 1 , further comprising detection circuitry with electrodes configured to detect an electrical complex in the patient's heart, wherein the control circuitry is further configured to control the delivery of electrical energy based on the detection of an electrical complex.
Claim 6
Dependent Claim
23 words
5 . The system of claim 4 , in which the detection circuitry is configured to detect a P-wave in the patient's heart.
Claim 7
Dependent Claim
31 words
6 . The system of claim 4 , in which the detection circuitry further produces a control signal that is communicated to the control circuitry signifying detection of an electrical complex.
Claim 8
Dependent Claim
34 words
7 . The system of claim 6 , in which the control circuitry is configured to cause the stimulation circuitry to deliver the electrical energy at a time determined based on the control signal.
Claim 9
Dependent Claim
20 words
8 . The system of claim 1 , in which the lead is formed to have one or more undulations.
Claim 10
Dependent Claim
41 words
9 . The system of claim 1 , in which the lead has one or more undulations that place the electrodes toward the muscle tissue proximate to the cardiac valve to be treated when the lead is implanted in the patient.
Claim 11
Dependent Claim
17 words
10 . The system of claim 1 , in which the lead is combined with a prosthesis.
Claim 12
Dependent Claim
17 words
11 . The system of claim 10 , in which the lead is attached to the prosthesis.
Claim 13
Dependent Claim
18 words
12 . The system of claim 10 , in which the lead is formed integrally with the prosthesis.
Claim 14
Dependent Claim
27 words
13 . The system of claim 10 , in which the prosthesis is formed to exert a mechanical pressure directed toward the cardiac valve to be treated.
Claim 15
Dependent Claim
108 words
14 . A cardiac valve constricting device, comprising: (a) electrodes configured for implantation in a patient such that the electrodes are in electrical communication with muscle tissue that is proximate to a cardiac valve to be constricted; (b) a detector configured to receive a physiological signal from the patient and, based on the physiological signal, produce a detection signal signifying detection of a contraction in the patient's heart; and (c) a stimulator configured to receive the detection signal and deliver electrical energy to the electrodes in time relation to the detection signal to cause the muscle tissue to contract and exert a constricting pressure on the cardiac valve.
Claim 16
Dependent Claim
108 words
14 . A cardiac valve constricting device, comprising: (a) electrodes configured for implantation in a patient such that the electrodes are in electrical communication with muscle tissue that is proximate to a cardiac valve to be constricted; (b) a detector configured to receive a physiological signal from the patient and, based on the physiological signal, produce a detection signal signifying detection of a contraction in the patient's heart; and (c) a stimulator configured to receive the detection signal and deliver electrical energy to the electrodes in time relation to the detection signal to cause the muscle tissue to contract and exert a constricting pressure on the cardiac valve.
Claim 17
Dependent Claim
25 words
15 . The cardiac valve constricting device of claim 14 , in which the physiological signal is an electrogram signal detected in the patient's heart.
Claim 18
Dependent Claim
25 words
16 . The cardiac valve constricting device of claim 15 , in which the detector is configured to detect a P-wave in the patient's heart.
Claim 19
Dependent Claim
40 words
17 . The cardiac valve constricting device of claim 14 , in which the stimulator is configured to deliver the electrical energy prior to or concurrent with another contraction in the patient's heart following the receipt of the detection signal.
Claim 20
Dependent Claim
36 words
18 . The cardiac valve constricting device of claim 17 , in which the detection signal signifies detection of an atrial contraction and the electrical energy is delivered prior to or concurrent with a ventricular contraction.
Claim 21
Dependent Claim
27 words
19 . The cardiac valve constricting device of claim 14 , in which the lead is configured to be received within a blood vessel in the patient.
Claim 22
Dependent Claim
38 words
20 . The cardiac valve constricting device of claim 19 , in which the blood vessel is the coronary sinus that places the electrodes next to muscle tissue that is proximate to the mitral valve of the patient.
Claim 23
Dependent Claim
99 words
21 . An electrical lead for treatment of cardiac valve dysfunction, comprising: (a) a length of electrically conductive material in an insulating substrate; and (b) a plurality of electrodes electrically connected to the conductive material; in which the electrically conductive material is configured for implementation in a patient such that the plurality of electrodes are in electrical communication with muscle tissue proximate to a cardiac valve to be treated, the plurality of electrodes being configured to deliver electrical energy to the muscle tissue to cause the muscle tissue to contract and exert a constricting pressure on the cardiac valve.
Claim 24
Dependent Claim
99 words
21 . An electrical lead for treatment of cardiac valve dysfunction, comprising: (a) a length of electrically conductive material in an insulating substrate; and (b) a plurality of electrodes electrically connected to the conductive material; in which the electrically conductive material is configured for implementation in a patient such that the plurality of electrodes are in electrical communication with muscle tissue proximate to a cardiac valve to be treated, the plurality of electrodes being configured to deliver electrical energy to the muscle tissue to cause the muscle tissue to contract and exert a constricting pressure on the cardiac valve.
Claim 25
Dependent Claim
20 words
22 . The electrical lead of claim 21 , in which the lead is formed with one or more undulations.
Claim 26
Dependent Claim
41 words
23 . The electrical lead of claim 21 , in which the lead has one or more undulations that place the plurality of electrodes in a position toward the muscle tissue that is proximate to the cardiac valve to be treated.
Claim 27
Dependent Claim
18 words
24 . The electrical lead of claim 21 , in which the lead is combined with a prosthesis.
Claim 28
Dependent Claim
18 words
25 . The electrical lead of claim 24 , in which the lead is attached to the prosthesis.
Claim 29
Dependent Claim
20 words
26 . The electrical lead of claim 24 , in which the electrical lead is formed integrally with the prosthesis.
Claim 30
Dependent Claim
39 words
27 . The electrical lead of claim 24 , in which the prosthesis is configured to exert a mechanical pressure directed toward the cardiac valve to be treated when the electrical lead and prosthesis are implanted in the patient.
Claim 31
Dependent Claim
69 words
28 . A device for treating dilated cardiomyopathy of the mitral valve in a patient's heart, comprising: (a) a lead with electrodes configured for implantation in the coronary sinus of the patient's heart; and (b) a stimulator in electrical communication with the lead electrodes for delivering electrical energy to the electrodes and stimulating contraction of muscle tissue proximate to the coronary sinus that causes the mitral valve to constrict.
Claim 32
Dependent Claim
69 words
28 . A device for treating dilated cardiomyopathy of the mitral valve in a patient's heart, comprising: (a) a lead with electrodes configured for implantation in the coronary sinus of the patient's heart; and (b) a stimulator in electrical communication with the lead electrodes for delivering electrical energy to the electrodes and stimulating contraction of muscle tissue proximate to the coronary sinus that causes the mitral valve to constrict.
Claim 33
Dependent Claim
21 words
29 . The device of claim 28 , further comprising a detector configured to detect a P-wave in the patient's heart.
Claim 34
Dependent Claim
32 words
30 . The device of claim 29 , in which the detector is further configured to produce a control signal that is communicated to the stimulator to signify detection of a P-wave.
Claim 35
Dependent Claim
31 words
31 . The device of claim 30 , in which the stimulator is configured to deliver electrical energy at a time determined based on the control signal received from the detector.
Claim 36
Dependent Claim
40 words
32 . The device of claim 30 , in which the control signal signifies detection of an atrial contraction and the stimulator is configured to deliver electrical energy to the lead electrodes prior to or concurrent with a ventricular contraction.
Claim 37
Dependent Claim
30 words
33 . The device of claim 28 , in which the lead has one or more undulations that place the electrodes toward the muscle tissue proximate to the mitral valve.
Claim 38
Dependent Claim
31 words
34 . The device of claim 28 , further comprising a prosthesis configured for implantation in the coronary sinus with the lead to exert constricting mechanical pressure on the mitral valve.
Claim 39
Dependent Claim
108 words
35 . A combined electromechanical therapy system for treatment of cardiac valve dysfunction, comprising: (a) an elongate member configured for implantation in a patient's heart to partially encircle the cardiac valve to be treated; (b) an electrical lead connected to the elongate member, the lead having a plurality of electrodes for delivering electrical energy to muscle tissue proximate to the cardiac valve when the elongate member is placed adjacent to the cardiac valve; and (c) a stimulator in electrical communication with the lead electrodes for delivering electrical energy to the electrodes to stimulate contraction of the muscle tissue and thereby exert a constricting pressure on the cardiac valve.
Claim 40
Dependent Claim
108 words
35 . A combined electromechanical therapy system for treatment of cardiac valve dysfunction, comprising: (a) an elongate member configured for implantation in a patient's heart to partially encircle the cardiac valve to be treated; (b) an electrical lead connected to the elongate member, the lead having a plurality of electrodes for delivering electrical energy to muscle tissue proximate to the cardiac valve when the elongate member is placed adjacent to the cardiac valve; and (c) a stimulator in electrical communication with the lead electrodes for delivering electrical energy to the electrodes to stimulate contraction of the muscle tissue and thereby exert a constricting pressure on the cardiac valve.
Claim 41
Dependent Claim
39 words
36 . The combined electromechanical therapy system of claim 35 , in which the elongate member is further configured to exert an inward constricting pressure on the cardiac valve when the member is placed adjacent to the cardiac valve.
Claim 42
Dependent Claim
27 words
37 . The combined electromechanical therapy system of claim 35 , in which the elongate member is attached to the muscle tissue proximate to the cardiac valve.
Claim 43
Dependent Claim
40 words
38 . The combined electromechanical therapy system of claim 35 , in which the elongate member and electrical lead are configured to be received within a blood vessel next to the muscle tissue and the cardiac valve to be treated.
Claim 44
Dependent Claim
39 words
39 . The combined electromechanical therapy system of claim 38 , in which the elongate member and electrical lead are configured to be implanted in a coronary sinus of the patient proximate to a mitral valve of the patient.
Claim 45
Dependent Claim
53 words
40 . The combined electromechanical therapy system of claim 38 , in which at least one end of the elongate member has a “V” shaped end portion having a leg that exerts a pressure toward a wall of the blood vessel resulting in an opposite inward pressure being directed toward the cardiac valve.
Claim 46
Dependent Claim
25 words
41 . The combined electromechanical therapy system of claim 35 , further comprising a detector configured to detect an electrical complex in the patient's heart.
Claim 47
Dependent Claim
19 words
42 . The combined electromechanical therapy system of claim 41 , in which the electrical complex is a P-wave.
Claim 48
Dependent Claim
35 words
43 . The combined electromechanical therapy system of claim 42 , in which the detector is further configured to produce a control signal that is communicated to the stimulator to signify detection of a P-wave.
Claim 49
Dependent Claim
35 words
44 . The combined electromechanical therapy system of claim 43 , in which the stimulator is configured to deliver the electrical energy to the lead electrodes at a time determined based on the control signal.
Claim 50
Dependent Claim
22 words
45 . The combined electromechanical therapy system of claim 35 , in which the electrical lead is integrated with the elongate member.
Claim 51
Dependent Claim
64 words
46 . A method for treating cardiac valve dysfunction, comprising: (a) implanting a lead with electrodes in a patient such that the electrodes are in electrical communication with muscle tissue proximate to a cardiac valve to be treated; and (b) delivering electrical energy to the lead electrodes to stimulate contraction of the muscle tissue, and thereby exert a constricting pressure on the cardiac valve.
Claim 52
Dependent Claim
64 words
46 . A method for treating cardiac valve dysfunction, comprising: (a) implanting a lead with electrodes in a patient such that the electrodes are in electrical communication with muscle tissue proximate to a cardiac valve to be treated; and (b) delivering electrical energy to the lead electrodes to stimulate contraction of the muscle tissue, and thereby exert a constricting pressure on the cardiac valve.
Claim 53
Dependent Claim
35 words
47 . The method of claim 46 , further comprising detecting an electrical complex in the patient's heart and delivering the electrical energy to the lead electrodes based on the detection of an electrical complex.
Claim 54
Dependent Claim
16 words
48 . The method of claim 47 , in which the electrical complex is a P-wave.
Claim 55
Dependent Claim
20 words
49 . The method of claim 47 , further comprising producing a control signal signifying detection of an electrical complex.
Claim 56
Dependent Claim
26 words
50 . The method of claim 49 , further comprising delivering electrical energy to the lead electrodes at a time determined based on the control signal.
Claim 57
Dependent Claim
21 words
51 . The method of claim 46 , in which the lead is implanted within a blood vessel in the patient.
Claim 58
Dependent Claim
27 words
52 . The method of claim 51 , in which the lead is implanted in the coronary sinus of the patient proximate to the patient's mitral valve.
Claim 59
Dependent Claim
15 words
53 . The method of claim 46 , further comprising forming undulations in the lead.
Claim 60
Dependent Claim
31 words
54 . The method of claim 53 , in which the undulations are formed to place the lead electrodes toward the muscle tissue proximate to the cardiac valve to be treated.
Claim 61
Dependent Claim
16 words
55 . The method of claim 46 , further comprising combining the lead with a prosthesis.
Claim 62
Dependent Claim
31 words
56 . The method of claim 55 , further comprising implanting the prosthesis in the patient such that the prosthesis exerts a mechanical pressure toward the cardiac valve to be treated.